1-3 of 3
Toshiyuki Araki
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A germline gain-of-function mutation in Ptpn11 (Shp-2) phosphatase induces myeloproliferative disease by aberrant activation of hematopoietic stem cells

Dan Xu, Siying Wang, Wen-Mei Yu, Gordon Chan, Toshiyuki Araki, Kevin D. Bunting, Benjamin G. Neel, Cheng-Kui Qu
Journal: Blood
Blood (2010) 116 (18): 3611–3621.
https://doi.org/10.1182/blood-2010-01-265652
Published: 2010
Includes: Supplemental data
Journal Articles

Activating Shp2 Mutations Cause Progressive Myeloproliferative Disorder in Mice.

M. Golam Mohi, PhD, Gordon Chan, Ph.D, Toshiyuki Araki, Ph.D., Wentien Yang, Ph.D., Lily Pao, Ph.D., Demetrios Kalaitzidis, Ph.D., Benjamin G. Neel, M.D., Ph.D.
Journal: Blood
Blood (2006) 108 (11): 3614.
https://doi.org/10.1182/blood.V108.11.3614.3614
Published: 2006
Journal Articles

Mechanism of Oncogenesis by Leukemia-Associated Mutants of Shp2 (PTPN11).

M. Golam Mohi, Ph.D, Heike Keilhack, Ph.D., Sarah Cohen, Christina Boulton, Toshiyuki Araki, Ph.D., Ifor Williams, M.D., Ph.D., Jeffery L. Kutok, M.D., Ph.D., D. Gary Gilliland, M.D., Ph.D., Benjamin G. Neel, M.D., Ph.D.
Journal: Blood
Blood (2004) 104 (11): 199.
https://doi.org/10.1182/blood.V104.11.199.199
Published: 2004